Skip to content
Alumis logo

Alumis Alternatives & Competitors

12 companies similar to Alumis — Transforming the lives of patients living with immune-mediated diseases using a...

Companies similar to Alumis

3T Biosciences logo — alternative to Alumis

3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for br...

Sudo Biosciences logo — alternative to Alumis

Sudo Biosciences

Developing precision TYK2 therapeutics.

ACELYRIN, INC. logo — alternative to Alumis

ACELYRIN, INC.

We are a late-stage clinical biopharma company focused on providing life-changing new trea...

HI-Bio: A Biogen Company logo — alternative to Alumis

HI-Bio: A Biogen Company

HI-Bio is a clinical-stage biotech company delivering targeted therapies for patients with...

Rival Readout

Competing with Alumis? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Entelexo Biotherapeutics logo — alternative to Alumis

Entelexo Biotherapeutics

Entelexo has created a novel platform technology for engineering exosomes as a new approac...

Dianthus Therapeutics, Inc. logo — alternative to Alumis

Dianthus Therapeutics, Inc.

Building a leading biotech company focused in severe autoimmune diseases.

Aro Biotherapeutics logo — alternative to Alumis
Expansion Therapeutics logo — alternative to Alumis

Expansion Therapeutics

Bringing transformative therapies to patients with severe RNA-mediated diseases.

ROME Therapeutics logo — alternative to Alumis

ROME Therapeutics

Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...

Adicet Bio, Inc logo — alternative to Alumis

Adicet Bio, Inc

A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...

Kite Pharma logo — alternative to Alumis

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

Tridek-One logo — alternative to Alumis

Tridek-One

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...

About Alumis

Alumis, founded in 2021 and headquartered in the United States, is making strides in the biotechnology, health care, and life sciences industries. The company is committed to transforming the lives of patients with immune-mediated diseases through a precise, targeted approach. By focusing on optimizing patient outcomes...

Services

Development of targeted therapies, Clinical trial management, Proprietary data analytics for precision medicine, Patient resources and expanded access policy

Target Customers

Patients with immune-mediated diseases, Healthcare providers, Medical researchers, Investors in biotech and pharmaceutical sectors

Business keywords

Immune-mediated Diseases, Precision Medicine, Targeted Therapies, Drug Development, Autoimmune Diseases, Immunology, Pharmaceuticals, Integrated Therapy Development, Immunosuppression Alternatives, Patient-centric Solutions, Disease-specific Drug Targeting, Therapeutic Innovation, Healthcare Analytics

Business Model

B2B, D2C, B2D

Revenue Model

Product Sales, Licensing, Performance Based

Frequently Asked Questions

Companies similar to Alumis include 3T Biosciences, Sudo Biosciences, ACELYRIN, INC., HI-Bio: A Biogen Company, Entelexo Biotherapeutics. They work in Biotechnology and Health Care and share Alumis's focus on drug development, autoimmune diseases and immune-mediated diseases.
Bounce Watch lists 12 companies that share Alumis's industries and are closest to it in business tags, services, target customers, business model and size.
Alumis, founded in 2021 and headquartered in the United States, is making strides in the biotechnology, health care, and life sciences industries. The company is committed to transforming the lives of patients with immune-mediated diseases through a precise, targeted approach. By focusing on optimizing patient outcomes...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Alumis: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Alumis on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout